LIVX yields 65.15% · JNJ yields 2.13%● Live data
📍 LIVX pulled ahead of the other in Year 1
Combined, LIVX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LIVX + JNJ for your $10,000?
LiveXLive Media, Inc. a digital media company, engages in the acquisition, distribution, and monetization of live music, Internet radio, podcasting, and music-related streaming and video content. The company is headquartered in West Hollywood, California and currently employs 76 full-time employees. The firm is focused on live music and music-related video content. The company operates an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival and Hangout Music Festival, as well as original content, artist exclusives and industry interviews. Its LiveXLive platform features performances and content from some of the artists in various music genres, including Rihanna, Katy Perry, Major Lazer and Maroon 5. The Company’s platform features all genres of music including rock, pop, alternative, electronic dance music (EDM), country and feature festival headliners as well as emerging artists performing at clubs and venues around the globe. Its portfolio includes KOKO, The Marquee, TAO, and Saban Theatre.
Full LIVX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.